4//SEC Filing
TERRELL JASON BRADLEY MD 4
Accession 0001078782-20-000595
CIK 0000093314other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 1:58 PM ET
Size
13.7 KB
Accession
0001078782-20-000595
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
TERRELL JASON BRADLEY MD
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-04$2.50/sh+12,500$31,250→ 62,500 total - Tax Payment
Common Stock
2020-08-04$3.55/sh−9,580$34,009→ 52,920 total - Exercise/Conversion
Common Stock
2020-08-04$3.00/sh+12,500$37,500→ 65,420 total - Tax Payment
Common Stock
2020-08-04$3.55/sh−10,971$38,947→ 54,449 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-04−12,500→ 0 totalExercise: $2.50From: 2015-02-18Exp: 2020-08-18→ Common Stock (12,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-04−12,500→ 0 totalExercise: $3.00From: 2016-02-18Exp: 2020-08-18→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001567531
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 1:58 PM ET
- Size
- 13.7 KB